STUDY THE EFFECTS OF HIGH AND LOW FREQUENCIES PULSED SQUARE ELECTROMAGNETIC FIELDS ON THE LOGARITHMIC GROWTH OF THE E.COLI
Journal Title: Journal of Atoms and Molecules - Year 2012, Vol 2, Issue 2
Abstract
The effect of high frequency electromagnetic fields (110 Hz with intensity of 700 milli gauss) and low frequency (10 Hz with intensity of 700 milli gauss) on the bacterium Escherichia coli (ATCC 1533) were studied. In this study, the bacterium Escherichia coli was cultured in BHI broth, then it was incubated in BHI (Brain Heart Infusion Agar) broth at 37°C for 24 hours then serial dilutions were made to and from the sixth dilution (10-4), one sample was treated with electromagnetic field for six hours and one put aside as control sample. The results showed a significant increase in the logarithm of the number of Escherichia coli (CFU/ml) treated with high frequency electromagnetic field and a significant decrease in the number of Escherichia coli (CFU/ml) exposed to lowfrequency electromagnetic field. The results of biochemical tests also showed negative effects of electromagnetic fields on the biochemical properties of Escherichia coli as a bacterium.
Authors and Affiliations
Saeed Nafisi, Asghar tanoomand, Kaveh Ebrahim Pour, Davoud Kardan, Seyyed Reza Moaddab
TL and PL Study of beta irradiated calcite collected from Semaria mines of C.G. Basin
The present paper reports the photoluminescence (PL) and thermoluminescence (TL) studies of natural calcite collected from Semaria mines of C.G. Basin. The sample was irradiated with Sr-90 beta source given a dose of 10G...
METHOD VALIDATION FOR DETERMINATION OF HEAVY METALS IN PHYTONADIONE EMULSION (I.M) DOSAGE FORMS BY ICP-MS
The analysis of pharma samples by ICP-MS is challenging due to their high carbon content. Because they are organic based and have a variety of compositions, present a special challenge for ICP-MS analysis: the carbon cau...
GREEN SYNTHESIS OF SILVER NANOPARTICLES USING Adhatoda vasica METHANOLIC EXTRACT AND ITS BIOLOGICAL ACTIVITIES
There is an increasing commercial demand for nanoparticles due to their wide applicability in various areas such as electronics, catalysis, chemistry, energy, and medicine. Metallic nanoparticles are traditionally synthe...
A NOVEL RP-HPLC METHOD FOR THE QUANTIFICATION OF RUXOLITINIB IN FORMULATIONS
A simple, precise and accurate RP-HPLC method was developed and validated for rapid assay of Ruxolitinib in tablet dosage form. Isocratic elution at a flow rate of 1ml/min was employed on a symmetry Chromosil C18 (250x4....
A REVIEW ARTICLE TO DEVELOP SUSTAIN RELEASE RIVAROXABAN FORMULATION
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto.[1] In the United States, it is marketed by Janssen Pharmaceutical.[2] It is the first available...